![](https://cdn.rttnews.com/articleimages/ustopstories/2024/july/gilead-24072024-lt.jpg)
Gilead's Twice-yearly Injection Offers 100% Protection Against HIV In Women: Study
In a recent study conducted by Gilead Sciences, Inc. (GILD) and published in the New England Journal of Medicine, it was revealed that a biannual injection of lenacapavir, a pre-exposure prophylaxis or PrEP drug, has been shown to provide complete …